These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 36147466

  • 1. Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells.
    Wu J, Shao X, Shen J, Lin Q, Zhu X, Li S, Li J, Zhou W, Qi C, Ni Z.
    Int J Biol Sci; 2022; 18(14):5438-5458. PubMed ID: 36147466
    [Abstract] [Full Text] [Related]

  • 2. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 3. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 11; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 4. [Effects of Gubentongluo Formula on Oxidative Stress Reflected by Expressions of PPARα and L-FABP in Mice with IgA Nephropathy].
    Li WW, Huang D, Shen PC, Wu Q, Sun C, Wang XX, He LQ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar 11; 48(2):210-215. PubMed ID: 28612528
    [Abstract] [Full Text] [Related]

  • 5. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.
    Leung JC, Tang SC, Lam MF, Chan TM, Lai KN.
    Kidney Int; 2001 Jan 11; 59(1):277-85. PubMed ID: 11135081
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of microRNA‑140‑3p mediates dachshund family transcription factor 1 expression in immunoglobulin A nephropathy through cell cycle‑dependent mechanisms.
    Zhou X, Lu Y, Guo P, Zhou C.
    Mol Med Rep; 2021 Feb 11; 23(2):. PubMed ID: 33313942
    [Abstract] [Full Text] [Related]

  • 7. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 8. Expression of immunoglobulin A in human mesangial cells and its effects on cell apoptosis and adhesion.
    Deng H, Ma J, Jing Z, Deng Z, Liang Y, A L, Liu Y, Qiu X, Wang Y.
    Mol Med Rep; 2018 Apr 29; 17(4):5272-5282. PubMed ID: 29393471
    [Abstract] [Full Text] [Related]

  • 9. Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.
    Dai Q, Liu J, Du YL, Hao X, Ying J, Tan Y, He LQ, Wang WM, Chen N.
    Acta Pharmacol Sin; 2016 Feb 29; 37(2):228-34. PubMed ID: 26775659
    [Abstract] [Full Text] [Related]

  • 10. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y, Liu X, Jia J, Zheng J, Yan T.
    J Transl Med; 2019 Sep 23; 17(1):320. PubMed ID: 31547815
    [Abstract] [Full Text] [Related]

  • 11. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
    Tamouza H, Vende F, Tiwari M, Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC, Moura IC.
    Contrib Nephrol; 2007 Sep 23; 157():144-7. PubMed ID: 17495453
    [Abstract] [Full Text] [Related]

  • 12. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARα; and repressed by C/EBPα: Implications in FABP1 down-regulation in nonalcoholic fatty liver disease.
    Guzmán C, Benet M, Pisonero-Vaquero S, Moya M, García-Mediavilla MV, Martínez-Chantar ML, González-Gallego J, Castell JV, Sánchez-Campos S, Jover R.
    Biochim Biophys Acta; 2013 Apr 05; 1831(4):803-18. PubMed ID: 23318274
    [Abstract] [Full Text] [Related]

  • 16. Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.
    Leung JC, Chan LY, Tang SC, Tam PC, Fenn J, Lai KN.
    Nephron Exp Nephrol; 2007 Apr 05; 107(3):e107-18. PubMed ID: 17957128
    [Abstract] [Full Text] [Related]

  • 17. Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes.
    Wang C, Liu X, Ye Z, Zhang J, Tang H, Chen Z, Zhang H, Lou T.
    Eur J Clin Invest; 2009 Jul 05; 39(7):561-7. PubMed ID: 19397686
    [Abstract] [Full Text] [Related]

  • 18. A ligand-induced structural change in fatty acid-binding protein 1 is associated with potentiation of peroxisome proliferator-activated receptor α agonists.
    Patil R, Mohanty B, Liu B, Chandrashekaran IR, Headey SJ, Williams ML, Clements CS, Ilyichova O, Doak BC, Genissel P, Weaver RJ, Vuillard L, Halls ML, Porter CJH, Scanlon MJ.
    J Biol Chem; 2019 Mar 08; 294(10):3720-3734. PubMed ID: 30598509
    [Abstract] [Full Text] [Related]

  • 19. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr 08; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 20. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
    Wang C, Ye M, Zhao Q, Xia M, Liu D, He L, Chen G, Peng Y, Liu H.
    Am J Nephrol; 2019 Apr 08; 49(4):307-316. PubMed ID: 30917363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.